ArticlebioRxiv : the preprint server for biology2025
MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cells.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
13 authors.
Funding
Abstract
Background: Existing breast cancer risk models inadequately identify individuals at latent risk, particularly among women without known genetic mutations or family history. Risk is often underestimated or overestimated due to reliance on population-level data and neglect of cellular aging and mechanobiological alterations. Methods: We profiled primary human mammary epithelial cells (HMECs) from women of varying ages and risk backgrounds using mechano-node-pore sensing (mechano-NPS), a high-throughput microfluidic platform that captures single-cell mechanical properties. Using machine learning, we developed a classifier, MechanoAge, to predict age-related mechanical phenotypes and introduce a novel index, mechano-RISQ, to quantify deviations linked to breast cancer risk. We further assessed the cytoskeletal protein keratin 14 (KRT14) as a molecular mediator of these mechanical states through overexpression and knockdown experiments. Findings: Cells from younger women carrying BRCA1/2 mutations or with a family history of breast cancer exhibited accelerated mechanical aging compared to age-matched controls. Elevated mechano-RISQ scores reflected an increased proportion of cells with "older" mechanical profiles. KRT14 overexpression induced an aged mechanical phenotype in younger cells, while knockdown partially reversed this state in older cells. CyTOF profiling and modeling showed KRT14 modulation impacted protein expression signatures associated with aging and risk, particularly in luminal cells. Interpretation: Mechanical properties of breast epithelial cells reflect biologic aging and cancer susceptibility. Mechano-RISQ offers a new approach for identifying individuals at elevated risk, especially among average-risk populations, and may complement existing risk models by incorporating biophysical measures of epithelial aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.